Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Anticancer Research|June 27, 2025
Amentoflavone Enhances the Anti-tumor Activity of Regorafenib by Promoting Apoptosis and Inhibiting NF-κB-mediated Metastasis in Hepatocellular CarcinomaKuang-Hsuan Lin, Chia-Jung Tsai, Ying-Tzu Chen, et al.
Journal of Nanobiotechnology|July 31, 2024
A multifunctional PEGylated liposomal-encapsulated sunitinib enhancing autophagy, immunomodulation, and safety in renal cell carcinomaPo-Fu Yueh, Chih-Sheng Chiang, I-Jung Tsai, et al.
In Vivo (Athens, Greece)|April 30, 2024
Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse ModelJr-DI Yang, Yu-Chang Liu, Hsiao-Chia Wang, et al.
International Journal of Oncology|May 9, 2014
Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signalingFei-Ting Hsu, Yu-Chang Liu, I-Tsang Chiang, et al.
Frontiers in Oncology|November 12, 2021
Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung CancerPo-Fu Yueh, Yuan-Hao Lee, I-Tsang Chiang, et al.
Bioscience Reports|March 15, 2018
Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing miceMao-Chi Weng, Mei-Hui Wang, Jai-Jen Tsai, et al.
Anticancer Research|April 30, 2022
Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to LenvatinibChe-Jui Yang, Meng-Hsuan Wu, Jai-Jen Tsai, et al.
Cancer Letters|July 4, 2026
An IL-15 fusion with albumin-binding domain boosts Immunotherapy therapy in glioblastoma via FGF-2 competition regulating FGFR1/2Yueh-Shan Weng, I-Tsang Chiang, Dai-Cheng Dong, et al.
In Vivo (Athens, Greece)|April 28, 2022
Reinforcement of Sorafenib Anti-osteosarcoma Effect by Amentoflavone Is Associated With the Induction of Apoptosis and Inactivation of ERK/NF-κBChun-Min Su, Chi-Huan Li, Meng-Chu Huang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2019
Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivoMao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, et al.
Pageof 13